DK3167389T3 - Titrering af basalinsulin med to driftstilstande - Google Patents

Titrering af basalinsulin med to driftstilstande Download PDF

Info

Publication number
DK3167389T3
DK3167389T3 DK15736504.0T DK15736504T DK3167389T3 DK 3167389 T3 DK3167389 T3 DK 3167389T3 DK 15736504 T DK15736504 T DK 15736504T DK 3167389 T3 DK3167389 T3 DK 3167389T3
Authority
DK
Denmark
Prior art keywords
basalinsulin
titration
operating modes
modes
operating
Prior art date
Application number
DK15736504.0T
Other languages
English (en)
Inventor
Andrew Tubb
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK3167389T3 publication Critical patent/DK3167389T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • External Artificial Organs (AREA)
DK15736504.0T 2014-07-11 2015-07-10 Titrering af basalinsulin med to driftstilstande DK3167389T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14176726.9A EP2966582A1 (en) 2014-07-11 2014-07-11 Titration of basal insulin with two modes
PCT/EP2015/065883 WO2016005586A2 (en) 2014-07-11 2015-07-10 Data management unit

Publications (1)

Publication Number Publication Date
DK3167389T3 true DK3167389T3 (da) 2022-02-21

Family

ID=51211041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15736504.0T DK3167389T3 (da) 2014-07-11 2015-07-10 Titrering af basalinsulin med to driftstilstande

Country Status (7)

Country Link
US (1) US11017891B2 (da)
EP (2) EP2966582A1 (da)
JP (1) JP6696962B2 (da)
CN (1) CN106687964B (da)
DK (1) DK3167389T3 (da)
TW (1) TWI787146B (da)
WO (1) WO2016005586A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110114833A (zh) * 2016-12-23 2019-08-09 赛诺菲-安万特德国有限公司 用于支持健康控制的数据管理单元
EP3559838B1 (en) * 2016-12-23 2024-07-03 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
CN110235205A (zh) * 2016-12-23 2019-09-13 赛诺菲-安万特德国有限公司 用于支持健康控制的数据管理单元
EP3618713B1 (en) 2017-05-05 2021-12-15 Eli Lilly and Company Closed loop control of physiological glucose
US11457863B1 (en) 2017-10-27 2022-10-04 Verily Life Sciences Llc Virtual health coach based insulin titration platform
CN111542884B (zh) 2017-12-21 2024-03-15 益首药物治疗股份公司 生理葡萄糖的闭环控制
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
JP2020106318A (ja) * 2018-12-26 2020-07-09 メディカルフォトニクス株式会社 吸収カロリー計測装置、吸収カロリー計測方法、及び、吸収カロリー計測プログラム
WO2023144364A1 (en) 2022-01-31 2023-08-03 Novo Nordisk A/S Systems and methods for personalized insulin titration

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0415035A (ja) * 1990-05-07 1992-01-20 Toyota Central Res & Dev Lab Inc 在宅療養支援システム
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
CN106955391B (zh) * 2009-02-04 2020-11-20 赛诺菲-安万特德国有限公司 用于提供用于血糖控制的信息的医疗设备和方法
WO2010089305A1 (en) * 2009-02-04 2010-08-12 Sanofi-Aventis Deutschland Gmbh Medical device and method for glycemic control
CA2957078C (en) * 2009-06-30 2019-04-30 Lifescan, Inc Analyte testing methods and device for calculating basal insulin therapy
US10010273B2 (en) * 2011-03-10 2018-07-03 Abbott Diabetes Care, Inc. Multi-function analyte monitor device and methods of use
US10293109B2 (en) 2011-09-13 2019-05-21 Novo Nordisk A/S Adaptive system for optimizing a drug dosage regimen over time
TWI551313B (zh) * 2013-05-24 2016-10-01 中臺科技大學 胰島素注射裝置
TWI690346B (zh) * 2014-11-17 2020-04-11 丹麥商錫蘭德醫藥公司 用於投與藥劑的注射裝置

Also Published As

Publication number Publication date
WO2016005586A3 (en) 2016-04-07
US11017891B2 (en) 2021-05-25
EP2966582A1 (en) 2016-01-13
TWI787146B (zh) 2022-12-21
CN106687964B (zh) 2022-09-13
JP6696962B2 (ja) 2020-05-20
EP3167389B1 (en) 2021-12-01
EP3167389A2 (en) 2017-05-17
CN106687964A (zh) 2017-05-17
US20170213009A1 (en) 2017-07-27
JP2017523832A (ja) 2017-08-24
TW201610870A (zh) 2016-03-16
WO2016005586A2 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3180331T3 (da) Polymorfer af selinexor
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3178817T3 (da) Amorf form af tetracyklisk forbindelse
DK2968208T3 (da) Behandling af kataplexi
DK3087183T3 (da) Modulation af angiopoietin-3-lignende ekspression
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3167389T3 (da) Titrering af basalinsulin med to driftstilstande
DK3117030T3 (da) Diagnosticering af sepsis
DK3514109T3 (da) Hydropyrolyse af biomasseholdige råmaterialer
DK3283210T3 (da) Fremgangsmåde
DK3220891T3 (da) Sublingual formulering af riluzol
DK3132009T3 (da) Fremgangsmåde
DK2965026T3 (da) Generering af slushice
DK3201323T3 (da) Modificering af bakteriofag
DK2968483T3 (da) Subkutan indgivelse af adamts13
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3418273T3 (da) Derivater af flavagliner
DK3511000T3 (da) Krystallinsk form x2 af grapiprant
DK3200783T3 (da) Behandling af erytromelalgi
FR3024647B1 (fr) Transat de puericulture
DK3285588T3 (da) Fremgangsmåde